Editor’s Commentary: Ethics in Clinical Research J. Rick Turner Commentary 30 December 2012 Pages: 155 - 157
Associate Editor’s Commentary: PEEKABOO—ETASU! Peter J. Pitts Commentary 30 December 2012 Pages: 158 - 159
Practical Considerations and Strategies for Executing Adaptive Clinical Trials Weili HeOlga M. KuznetsovaJerald Schindler Clinical Trials 30 December 2012 Pages: 160 - 174
Testing in a Prespecified Subgroup and the Intent-to-Treat Population Mark D. RothmannJenny J. ZhangThomas R. Fleming Clinical Trials 30 December 2012 Pages: 175 - 179
Industry Support of Key Opinion Leaders Elizabeth NegliaNina Singh-RadcliffW. Andrew Kofke Drug Information 30 December 2012 Pages: 180 - 184
Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force Richard GliklichJudith GlennieNancy A. Dreyer Drug Information 30 December 2012 Pages: 185 - 191
An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools John E. CalfeeElizabeth DuPré Drug Information 30 December 2012 Pages: 192 - 196
Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products J. Michael Nicholas Drug Information 30 December 2012 Pages: 197 - 206
Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain Mónica GómezMercedes Rozano Drug Information 30 December 2012 Pages: 207 - 215
Transparency in Drug Submission Processes of 3 Asian Countries: A Survey of Industry Views Martin SolbergFrances J. R. Richmond Drug Information 30 December 2012 Pages: 216 - 225
Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals Adrienne E. FaerberDavid H. Kreling Drug Information 30 December 2012 Pages: 226 - 234
Review of Genotoxic Impurities: Strategies for Identification and Control Theresa Allio Book Reviews 30 December 2012 Pages: 235 - 236
Review of Translational Medicine and Drug Discovery Edward Tabor Book Reviews 30 December 2012 Pages: 237 - 237
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs Frank J. Sasinowski Special Section 30 December 2012 Pages: 238 - 263